Skip to main content

Table 1 Results of stability, accuracy, precision, recovery and matrix effect in quality control samples (n = 6)

From: Determination of endogenous sphingolipid content in stroke rats and HT22 cells subjected to oxygen-glucose deprivation by LC‒MS/MS

Analyte

Sample

Added concentrations in QCs (ng/mL)

Matrix effect (%)

Stability (RSD, %)

Recovery (mean ± SD, %)

Intra- and Intraday accuracy (RE, %)

Intra- and Intraday precision (RSD, %)

Sphinganine (d16:0)

Brain

3

2000

4000

108.1

98.3

94.0

11.2

8.4

L:83.6 ± 4.2

M:88.5 ± 3.6

H:82.0 ± 6.1

97.8–103.1

3.6–5.8

Blood

3

1000

3000

102.9

96.8

106.8

4.1

4.3

L:90.8 ± 4.9

M:82.7 ± 3.5

H:83.2 ± 7.6

97.3–99.9

1.4–11.9

Cell

3

2400

3600

98.0

93.8

110.4

5.8

9.8

L:91.2 ± 5.8

M:92.8 ± 4.1

H:80.5 ± 7.4

98.7–100.9

3.3–7.6

S1P

Brain

10

200

400

98.9

99.6

98.2

10.9

4.7

L:90.2 ± 2.1

M:88.3 ± 4.5

H:87.2 ± 1.6

94.5–109.6

5.4–8.3

Blood

10

125

375

100.4

102.2

92.3

7.2

6.7

L:83.4 ± 2.7

M:93.3 ± 4.1

H:91.5 ± 3.4

100.1–101.8

3.1–7.4

Cell

10

36

54

105.1

102.0

98.6

10.9

8.3

L:102.4 ± 5.6

M:87.8 ± 2.4

H:94.1 ± 3.1

101.2–103.8

2.6–4.8

Sphinganine (d18:0)

Brain

3

8000

16,000

99.6

92.8

98.7

7.1

5.6

L:85.1 ± 1.9

M:90.8 ± 2.0

H:83.7 ± 1.8

96.1–108.3

6.1–10.2

Blood

3

5000

15,000

106.5

95.9

95.1

12.4

10.2

L:91.4 ± 2.2

M:84.7 ± 4.6

H:96.6 ± 4.2

99.4–104.8

6.5–9.0

Cell

3

6000

9000

95.3

94.3

100.9

4.8

7.5

L:83.1 ± 6.8

M:92.3 ± 1.4

H:87.2 ± 5.7

99.4–99.9

2.1–6.2

Phytosphingosine

Brain

3

4000

8000

105.7

105.4

93.2

7.8

8.1

L:89.7 ± 3.6

M:91.7 ± 2.1

H:92.3 ± 4.0

92.3–107.4

4.6–9.1

Blood

3

5000

15,000

100.4

95.7

94.1

4.6

7.0

L:91.4 ± 1.2

M:83.4 ± 2.8

H:97.4 ± 6.4

98.7–103.9

2.1–11.8

Cell

3

3000

4500

101.7

103.5

100.9

9.6

5.9

L:81.6 ± 2.3

M:91.8 ± 3.7

H:90.1 ± 5.4

97.9–99.3

2.8–4.9